Small-Molecule Receptor-Interacting Protein 1 (RIP1) Inhibitors as Therapeutic Agents for Multifaceted Diseases: Current Medicinal Chemistry Insights and Emerging Opportunities-Reference-Cited by-同舟云学术

Small-Molecule Receptor-Interacting Protein 1 (RIP1) Inhibitors as Therapeutic Agents for Multifaceted Diseases: Current Medicinal Chemistry Insights and Emerging Opportunities

Published:2022-11-08 Issue:22 Volume:65 Page:14971-14999
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Shi Kunyu¹,Zhang Jifa¹²³^ORCID,Zhou Enda⁴,Wang Jiaxing⁵,Wang Yuxi¹²³^ORCID

Affiliation:

1. Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Joint Research Institution of Altitude Health, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041 Sichuan, China

2. Precision Medicine Key Laboratory of Sichuan Province & Precision Medicine Research Center, West China Hospital, Sichuan University, Chengdu, 610041 Sichuan, China

3. Tianfu Jincheng Laboratory, Chengdu, 610041 Sichuan, China

4. West China School of Pharmacy, Sichuan University, Chengdu, 610041 Sichuan, China

5. Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States

Funder

Ministry of Science and Technology of the People's Republic of China

Natural Science Foundation of Sichuan Province

National Natural Science Foundation of China

Sichuan Province

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine